ASP Isotopes (ASPI) vs Codexis (CDXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Codexis (CDXS) has outperformed ASP Isotopes (ASPI) over the past year, losing 34.4% versus a loss of 81.6%. ASP Isotopes is the larger company by market cap ($171.4 million vs $110.7 million), about 1.5 times the size. Codexis converts more of its revenue into profit, with a net margin of -62.5% versus -670.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASPI | CDXS |
|---|---|---|
| Share price | $1.10 | $1.01 |
| Market cap | $171.42M | $110.69M |
| 1-day change | -3.08% | -3.81% |
| YTD return | -79.44% | -38.04% |
| 1-year return | -81.57% | -34.42% |
| 5-year return | — | -97.24% |
| EPS (TTM) | $-1.55 | $-0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $23.85M | $70.39M |
| Revenue growth (YoY) | +475.51% | +18.61% |
| Net income (latest FY) | $-159.84M | $-43.97M |
| Gross margin | 14.28% | 86.73% |
| Operating margin | -251.20% | -59.30% |
| Net margin | -670.23% | -62.47% |
| 52-week high | $8.60 | $2.98 |
| 52-week low | $1.03 | $0.90 |
| Distance from 52-week high | -87.21% | -66.11% |
| Analyst consensus | none | buy |
| Avg. price target upside | +1081.82% | +507.92% |
| Average volume | 4.45M | 918.15K |
| Shares outstanding | 155.83M | 109.60M |
| Employees | 271 | 146 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CDXS has outperformed ASPI by 47.2 percentage points over the past year.
- Codexis is more profitable, keeping -62.5 cents of every revenue dollar as net income versus -670.2 cents for ASP Isotopes.
- ASP Isotopes grew revenue faster in its latest fiscal year (+475.51% vs +18.61%).
About ASP Isotopes
ASPI stock →ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services.
Industrials · Major Chemicals · 271 employees
About Codexis
CDXS stock →Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
Industrials · Major Chemicals · 146 employees
ASPI vs CDXS FAQ
Which is bigger, ASP Isotopes or Codexis?
ASP Isotopes (ASPI) is larger, with a market capitalization of $171.42M compared with $110.69M for Codexis (CDXS).
Which stock has performed better over the past year, ASPI or CDXS?
CDXS returned -34.42% over the past 12 months, compared with -81.57% for ASPI (price return, excluding dividends). Past performance does not predict future results.
Are ASP Isotopes and Codexis in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.